Financials in CAD. Standardized financial statements.
A compact view of how Fennec Pharmaceuticals Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $45.42M | $47.54M | $21.25M | $1.53M | $0 | $170,000 | $0 | $0 | $0 | $0 |
| Revenue Growth? | -4.4% | +123.7% | +1284.5% | 0.0% | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.83M | $3.18M | $1.26M | $86,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $41.59M | $44.35M | $19.99M | $1.45M | $0 | $170,000 | $0 | $0 | $0 | $0 |
| Gross Margin? | +91.6% | +93.3% | +94.1% | +94.4% | 0.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $48.46M | $41.79M | $32.76M | $24.04M | $17.22M | $18.05M | $13.01M | $10.41M | $6.95M | $2.87M |
| Operating Income? | -$6.86M | $2.57M | -$12.77M | -$22.59M | -$17.22M | -$17.89M | -$13.01M | -$10.41M | -$6.95M | -$2.87M |
| EBITDA? | -$6.86M | $4.80M | -$12.65M | -$22.74M | -$17.18M | -$17.98M | -$13.01M | -$10.58M | -$6.82M | -$2.96M |
| Income Before Tax | -$10.27M | -$71,000 | -$16.05M | -$23.71M | -$17.35M | -$18.11M | -$12.78M | -$9.89M | -$7.05M | -$2.79M |
| Income Tax Expense | $0 | $365,000 | $0 | $147,000 | $110,000 | $0 | $0 | $0 | $48,000 | $0 |
| Net Income? | -$10.27M | -$436,000 | -$16.05M | -$23.86M | -$17.46M | -$18.11M | -$12.46M | -$9.89M | -$7.05M | -$2.79M |
| EPS? | $-0.36 | $-0.02 | $-0.60 | $-0.91 | $-0.67 | $-0.76 | $-0.63 | $-0.52 | $-0.47 | $-0.22 |
| Diluted EPS? | $-0.36 | $-0.02 | $-0.60 | $-0.91 | $-0.67 | $-0.76 | $-0.63 | $-0.52 | $-0.47 | $-0.22 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality